Review
doi: 10.1089/cap.2006.0116.
Commentary by an academic child psychiatrist on the relationship of the pharmaceutical industry, academia, psychiatric practice, and the Food and Drug Administration
Affiliations
- PMID: 17630861
- DOI: 10.1089/cap.2006.0116
Item in Clipboard
Review
Commentary by an academic child psychiatrist on the relationship of the pharmaceutical industry, academia, psychiatric practice, and the Food and Drug Administration
J Child Adolesc Psychopharmacol.
2007 Jun.
No abstract available
Similar articles
-
Commentary by an academic child and adolescent psychiatrist.J Child Adolesc Psychopharmacol. 2007 Jun;17(3):300-2. doi: 10.1089/cap.2007.0001. J Child Adolesc Psychopharmacol. 2007. PMID: 17630863 Review. No abstract available.
-
Commentary by a child psychiatrist practicing in a community setting.J Child Adolesc Psychopharmacol. 2007 Jun;17(3):295-9. doi: 10.1089/cap.2007.0002. J Child Adolesc Psychopharmacol. 2007. PMID: 17630862 Review. No abstract available.
-
Partnerships between academic psychiatry and the pharmaceutical industry: the Lilly MAP Initiative.Australas Psychiatry. 2004 Sep;12(3):220-4; discussion 225-6. doi: 10.1080/j.1039-8562.2004.02107.x. Australas Psychiatry. 2004. PMID: 15715778
-
Uneasy alliance--clinical investigators and the pharmaceutical industry.N Engl J Med. 2000 May 18;342(20):1539-44. doi: 10.1056/NEJM200005183422024. N Engl J Med. 2000. PMID: 10816196 No abstract available.
-
Translation of cancer immunotherapies.Nat Med. 2004 Nov;10(11):1153; author reply 1153-4. doi: 10.1038/nm1104-1153a. Nat Med. 2004. PMID: 15516900 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
